-
Typical and Atypical Patterns of Language and Literacy in Dual Language Learners (R01-Clinical Trial Optional)
(PA-18-316)
National Institute on Deafness and Other Communication Disorders
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt Date(s): Standard dates apply by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Typical and Atypical Patterns of Language and Literacy in Dual Language Learners (R21-Clinical Trial Optional)
(PA-18-328)
National Institute on Deafness and Other Communication Disorders
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Investigator-Initiated Clinical Trials Targeting Diseases within the Mission of NIDDK (R01-Clinical Trial Required)
(PA-18-330)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Testing Interventions for Health-Enhancing Physical Activity (R01 - Clinical Trial Optional)
(PAR-18-324)
Office of Disease Prevention
National Institute on Alcohol Abuse and Alcoholism
National Institute on Aging
National Cancer Institute
National Institute on Drug Abuse
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Center for Complementary and Integrative Health
National Institute on Minority Health and Health Disparities
Application Receipt Date(s): New applications: February 5, 2018; October 5, 2018; June 5, 2019; February 5, 2020; October 5, 2020, by 5:00 PM local time of applicant organization.
-
Simulation Modeling and Systems Science to Address Health Disparities (R01-Clinical Trial Not Allowed)
(PAR-18-331)
National Institute on Minority Health and Health Disparities
National Institute on Alcohol Abuse and Alcoholism
National Institute on Aging
National Cancer Institute
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Heart, Lung, and Blood Institute
National Library of Medicine
National Institute of Mental Health
National Institute of Biomedical Imaging and Bioengineering
Office of Behavioral and Social Sciences Research
Office of Disease Prevention
Application Receipt Date(s): January 10 2018; June 6, 2018; January 8, 2019; June 7, 2019
, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Clinic Testing Therapeutic/Indication Pairing Strategies (U01 Clinical Trial Required)
(PAR-18-332)
National Center for Advancing Translational Sciences
National Center for Advancing Translational Sciences
Application Receipt Date(s): Standard dates, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
NHLBI Program Project Applications (P01 - Clinical Trials Optional)
(PAR-18-405)
National Heart, Lung, and Blood Institute
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Maintaining Immunity After Immunization (U01 - Clinical Trial Optional)
(RFA-AI-17-034)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): February 21, 2018, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on this date.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Human Tumor Atlases (HTA) Research Centers (U2C)
(RFA-CA-17-034)
National Cancer Institute
Application Receipt Date(s): January 18, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
-
Human Tumor Atlases (HTA) Precancer Atlas Research Centers (U2C)
(RFA-CA-17-035)
National Cancer Institute
Application Receipt Date(s): January 18, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
-
Human Tumor Atlas Network: Data Coordinating Center (U24)
(RFA-CA-17-036)
National Cancer Institute
Application Receipt Date(s): January 18, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
-
Accelerating Colorectal Cancer Screening and follow-up through Implementation Science (ACCSIS)(UG3/UH3)
(RFA-CA-17-038)
National Cancer Institute
Application Receipt Date(s): January 18, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
-
Accelerating Colorectal Cancer Screening and follow-up through Implementation Science (ACCSIS): Coordinating Center (U24)
(RFA-CA-17-039)
National Cancer Institute
Application Receipt Date(s): January 18, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
-
Research Centers for Improving Management of Symptoms Across Cancer Treatments (IMPACT) (UM1)
(RFA-CA-17-042)
National Cancer Institute
Application Receipt Date(s): January 17, 2018), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
No late applications will be accepted for this FOA
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Coordinating Center for Improving Management of Symptoms Across Cancer Treatments (IMPACT) (U24)
(RFA-CA-17-043)
National Cancer Institute
Application Receipt Date(s): January 17, 2018), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
No late applications will be accepted for this FOA.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Mechanisms of Cancer Drug Resistance and Sensitivity: Coordinating Center (U24)
(RFA-CA-17-044)
National Cancer Institute
Application Receipt Date(s): January 5, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
No late applications will be accepted for this FOA
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Limited Competition: NCI National Clinical Trials Network - Network Group Operations Centers (U10)
(RFA-CA-17-056)
National Cancer Institute
Application Receipt Date(s): January 19, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
-
Limited Competition: NCI National Clinical Trials Network - Network Group Statistics and Data Management Centers (U10)
(RFA-CA-17-057)
National Cancer Institute
Application Receipt Date(s): January 19, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
-
Limited Competition: NCI National Clinical Trials Network - Canadian Collaborating Clinical Trials Network (U10)
(RFA-CA-17-058)
National Cancer Institute
Application Receipt Date(s): January 19, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
-
NCI National Clinical Trials Network (NCTN)--Network Lead Academic Participating Sites (UG1)
(RFA-CA-17-059)
National Cancer Institute
Application Receipt Date(s): January 19, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
-
Limited Competition: NCI National Clinical Trials Network - Network Radiotherapy and Imaging Core Services Center (U24)
(RFA-CA-17-060)
National Cancer Institute
Application Receipt Date(s): January 19, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
-
NCI National Clinical Trials Network - Network Group Integrated Translational Science Centers (UG1)
(RFA-CA-17-061)
National Cancer Institute
Application Receipt Date(s): January 19, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
-
Building Research Capacity in Global Tobacco Product Regulation Program (U18)
(RFA-FD-18-003)
Food and Drug Administration
Application Receipt Date(s): December 18, 2017 by 11:59 PM Eastern Time.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date.
Late applications will not be accepted for this FOA.
-
Regional Technology Transfer Accelerator Hubs for IDeA States (STTR) (UT2 - Clinical Trial Not Allowed)
(RFA-GM-18-001)
National Institute of General Medical Sciences
Application Receipt Date(s): January 5, 2018, by 5:00 PM local time of applicant organization.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Prevention and Treatment through a Comprehensive Care Continuum for HIV-affected Adolescents in Resource Constrained Settings (PATC3H) (UG3/UH3)
(RFA-HD-18-032)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Alcohol Abuse and Alcoholism
Office of Behavioral and Social Sciences Research
National Institute on Minority Health and Health Disparities
Application Receipt Date(s): December 22, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.